Organization
KP Pharmaceuticals LLC
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
KP Pharmaceuticals LLC
... Pharmaceuticals, Mr. Golubieski was Senior Vice President, Financial Planning & Analysis of King Pharmaceuticals until its acquisition by Pfizer for approximately $3.6 billion. Prior to ...
... Head of Licensing and Business Development for Meridian's former parent company, King Pharmaceuticals, Inc., until its acquisition by Pfizer in 2011. Previous to joining King ...
... to block a competitor. At the time, Meridian and its owner, Tennessee-based King Pharmaceuticals, were producing the EpiPen for Dey, a subsidiary of Merck KGaA, ...
... through a series of its own acquisitions. The firm was purchased by King Pharmaceuticals in 2003; King was acquired by Pfizer in 2011. And that's ...
... Schulman, accusing them of illegally trading in advance of the acquisition of King Pharmaceuticals in 2010. Mr. Schulman represented the company in patent litigation and ...
... tenacious people," according to John Gregory, who served as CEO of King Pharmaceuticals Inc. when Ernie was on its board in the 1990s and when ...
... Imcor Pharmaceutical - Immunomedics - Insight Agents - Jiangsu Hengrui Medicine - King Pharmaceuticals - Lantheus Medical Imaging - Macrocyclics - MDS Nordion - Nanopet ...
... dpiX -- FluoroPharma Medical -- GE Healthcare -- Johnson & Johnson -- King Pharmaceuticals -- Lantheus Medical Imaging -- LipScience -- Medison America -- Molecular ...
... used in the manufacture of the licensed drug candidates. In 2005, King Pharmaceuticals, Inc. entered into an agreement with Pain Therapeutics to develop and commercialize ...
... Tennessee. The lawsuit claims that Mutual Pharmaceutical Company, Inc. conspired with King Pharmaceuticals, Inc. to prevent and delay generic competition to King's brand-name drug, Skelaxin, ...
Subscribe now for full coverage on KP Pharmaceuticals LLC
Start My Free Trial